Diagnostische Möglichkeiten in der Bildgebung des Nierenzellkarzinoms

Die Bildgebung der Niere hat in den letzten Jahren enorme Fortschritte erzielt. Dieser Beitrag gibt einen Überblick über die zurzeit zur Verfügung stehenden radiologischen Techniken zur Bildgebung von Nierentumoren und diskutiert in Entwicklung befindliche Techniken.

• Literatur

• 1 Clevert DA. et al. Modern imaging of kidney tumors. Urologe A 2013; 52: 515-526
• 2 Braunagel M. et al. The role of functional imaging in the era of targeted therapy of renal cell carcinoma. World J Urol 2014; 32: 47-58
• 3 Notohamiprodjo M. et al. Imaging of Metastastic Renal Cell Carcinoma under Therapy with Immune Checkpoint Inhibitors. Fortschr Röntgenstr 2017; 189: 287-292
• 4 Rummeny EJ. Ganzkörper-MR-Tomografie. Stuttgart: Thieme; 2006 3. Auflage.
• 5 Reznek RH. CT/MRI in staging renal cell carcinoma. Cancer Imag 2004; 4: S25-S32
• 6 Kreft BP. et al. Diagnostic value of MR imaging in comparison to CT in the detection and differential diagnosis of renal masses: ROC analysis. Europ Radiol 1997; 7: 542-547
• 7 Henrichs B, Walsh RP. Intraoperative magnetic resonance imaging for neurosurgical procedures: anesthetic implications. AANA J 2011; 79: 71-77
• 8 Baikoussis NG. et al. Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. Annals Thora Surg 2011; 91: 2006-2011
• 9 Sun MR. et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiol 2009; 250: 793-802
• 10 Thomsen HS. et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Europ Radiol 2013; 23: 307-318
• 11 Nephrogenic systemic Fibrosis (NSF), in ACR Manual on Contrast Media. 2012: 63-71
• 12 Wang Y. et al. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiol 2011; 260: 105-111
• 13 Radbruch A. et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiol 2015; 275: 783-791
• 14 www.mrisafety.com
• 15 Ganeshan D. et al. Recent advances in cross-sectional renal imaging-an oncologic perspective: the current concepts and the future challenges. J Comput Assist Tomogr 2013; 37: 962-970
• 16 Ruppert-Kohlmayr AJ. et al. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. Am J Roentgenol 2004; 183: 1387-1391
• 17 Karlo CA. et al. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters. Europ Radiol 2013; 23: 1738-1744
• 18 Karlo CA. et al. Renal Cell Carcinoma: Role of MR Imaging in the Assessment of Muscular Venous Branch Invasion. Radiol 2013; 267: 454-459
• 19 Notohamiprodjo M. et al. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study. J Magn Reson Imag 2010; 31: 490-501
• 20 Notohamiprodjo M. et al. Diffusion tensor imaging (DTI) of the kidney at 3 tesla-feasibility, protocol evaluation and comparison to 1.5 Tesla. Invest Radiol 2010; 45: 245-254
• 21 Winter KS. et al. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor. Invest Radiol 2014; 49: 720-727